Journal of Cancer Research and Therapeutics Close
 

Figure 4: Fluorescence in situ hybridization test using break-apart probe (EWSR1 22q12 translocation), 60% tumor cells showed positivity

Figure 4: Fluorescence <i>in situ</i> hybridization test using break-apart probe (EWSR1 22q12 translocation), 60% tumor cells showed positivity